Mortality in patients with atrial fibrillation and heart failure.
作者信息
Fauchier Laurent, Gorin Laurent
出版信息
J Am Coll Cardiol. 2010 Jan 12;55(2):168; author reply 168-9. doi: 10.1016/j.jacc.2009.06.061.
PMID:20117389
Abstract
摘要
相似文献
1
Mortality in patients with atrial fibrillation and heart failure.
J Am Coll Cardiol. 2010 Jan 12;55(2):168; author reply 168-9. doi: 10.1016/j.jacc.2009.06.061.
2
Guidelines for atrial fibrillation in heart failure need to be clarified.
J Am Coll Cardiol. 2010 Jan 12;55(2):167; author reply 168-9. doi: 10.1016/j.jacc.2009.05.081.
3
[Atrial fibrillation--etiology, pathophysiological mechanisms, and therapy].
Nihon Rinsho. 2007 May 28;65 Suppl 5:359-63.
4
[Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options].
Dtsch Med Wochenschr. 2008 Nov;133(45):2349-54. doi: 10.1055/s-0028-1100927. Epub 2008 Oct 28.
5
Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.
Cardiovasc Res. 2007 Apr 1;74(1):8-10. doi: 10.1016/j.cardiores.2007.02.011. Epub 2007 Feb 14.
6
Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?
Am J Cardiol. 2004 Sep 15;94(6):797-800. doi: 10.1016/j.amjcard.2004.06.009.
7
8
Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Pharmacotherapy. 2009 Jan;29(1):31-48. doi: 10.1592/phco.29.1.31.
9
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Eur J Clin Invest. 2011 Jul;41(7):719-33. doi: 10.1111/j.1365-2362.2010.02460.x. Epub 2011 Jan 20.
10
[Atrial fibrillation and renin-angiotensin system].
Nihon Rinsho. 2007 Mar;65(3):569-74.
Zotero 插件